These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


614 related items for PubMed ID: 6607711

  • 1. [Monoclonal antibodies produced by human-human hybridomas].
    Chida J.
    Gan To Kagaku Ryoho; 1984 Jan; 11(1):157-64. PubMed ID: 6607711
    [Abstract] [Full Text] [Related]

  • 2. Determination of the optimal human cell lines for development of human hybridomas.
    Abrams PG, Knost JA, Clarke G, Wilburn S, Oldham RK, Foon KA.
    J Immunol; 1983 Sep; 131(3):1201-4. PubMed ID: 6350451
    [Abstract] [Full Text] [Related]

  • 3. Production of anti-tumor human monoclonal antibodies using different approaches.
    Liu H, Xu ZL, Wang Y, Yang L, Feng O, Li Y, Wang YM, Zhang GG.
    Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
    [Abstract] [Full Text] [Related]

  • 4. Production of human-human hybridomas secreting antibody to sheep erythrocytes after in vitro immunization.
    Strike LE, Devens BH, Lundak RL.
    J Immunol; 1984 Apr; 132(4):1798-803. PubMed ID: 6699402
    [Abstract] [Full Text] [Related]

  • 5. [Human monoclonal antibodies with human-mouse hybridomas].
    Naoe T, Kato K, Shiku H, Yamada K.
    Gan To Kagaku Ryoho; 1983 Dec; 10(12):2575-81. PubMed ID: 6606396
    [Abstract] [Full Text] [Related]

  • 6. Analysis of human monoclonal antibodies derived from lymphocytes of patients with cancer.
    Cote RJ, Morrissey DM, Oettgen HF, Old LJ.
    Fed Proc; 1984 Jun; 43(9):2465-9. PubMed ID: 6327400
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Lymphocyte surface marker expression on hybridomas secreting human monoclonal antibodies.
    Seifert M, Jahn S, Schwab J, Döcke W, Volk HD, von Baehr R.
    Hum Antibodies Hybridomas; 1992 Apr; 3(2):86-92. PubMed ID: 1633269
    [Abstract] [Full Text] [Related]

  • 12. Efficient electric field-induced generation of hybridomas from human B lymphocytes without prior activation in vitro.
    Kwekkeboom J, de Groot C, Tager JM.
    Hum Antibodies Hybridomas; 1992 Jan; 3(1):48-53. PubMed ID: 1576322
    [Abstract] [Full Text] [Related]

  • 13. Monoclonal antibodies: methods and clinical laboratory applications.
    Nakamura RM.
    Clin Physiol Biochem; 1983 Jan; 1(2-5):160-72. PubMed ID: 6396016
    [Abstract] [Full Text] [Related]

  • 14. Human monoclonal antibody to purified protein derivative of tuberculin produced by hybrids constructed with Epstein-Barr virus-transformed B lymphocytes and mouse myeloma cells.
    Garzelli C, Puglisi C, Falcone G.
    Eur J Immunol; 1986 May; 16(5):584-7. PubMed ID: 3009205
    [Abstract] [Full Text] [Related]

  • 15. [Study of anticancer human monoclonal antibody--establishment of human monoclonal antibody to gastric cancer by human-mouse hybridoma].
    Liu H.
    Zhonghua Zhong Liu Za Zhi; 1988 Jul; 10(4):242-4. PubMed ID: 3248478
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cell biology of human IgM-producing hybridomas derived from a fusion of human spleen lymphocytes with mouse myeloma cells.
    Jahn S, Grunow R, Kiessig ST, Bogacheva GT, Arsenjeva EL, Hlinak A, Rocklin OV, von Baehr R.
    Hybridoma; 1987 Dec; 6(6):679-87. PubMed ID: 3436627
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 31.